Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Paravertebral Block for Inguinal Hernia Repair in Elderly
NCT02537860Completed
- Sponsor
- Makassed General Hospital
- Start
- Dec 2015
- Primary completion
- Dec 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial of bupivacaine hydrochloride 0.75% injection in inguinal hernia (2 arms), sponsored by Makassed General Hospital. Primary endpoint: Mean Arterial Pressure. Started Dec 2015; status: completed.
02
Drugs
bupivacaine hydrochloride 0.75% injection
03
Conditions
inguinal hernia
Beyond the preview
Go deeper on NCT02537860.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02537860.